Here are five key points:
1. The market was valued at $12.6 billion in 2016.
2. The global spinal and neurostimulation intervention products market will continue to grow at a compound annual growth rate of 4.5 percent through 2021.
3. The market’s largest segment is spine surgery, which is expected to increase from $9 billion in 2016 to $10.8 billion in 2021.
4. The market’s spine surgery segment will continue to grow at a CAGR of 3.5 percent.
5. The neurostimulation devices segment will likely reach $5 billion in 2021, growing at a CAGR of 6.9 percent throughout the forecast period.
More articles on devices:
House introduces bill to permanently repeal medical device tax: 4 things to know
Titan Medical names David McNally new CEO — 7 key points
NuVasive receives approval to continue XLIF procedures in Japan— 6 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
